|
1
|
Chien J and Poole EM: Ovarian cancer
prevention, screening, and early detection: Report from the 11th
biennial ovarian cancer research symposium. Int J Gynecol Cancer.
27 9S Suppl 5:S20–S22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi JY, Lee S, Yun SM, Suh DH, Kim K, No
JH, Jeong EH and Kim YB: Active hexose correlated compound (AHCC)
inhibits the proliferation of ovarian cancer cells by suppressing
signal transducer and activator of transcription 3 (STAT3)
activation. Nutr Cancer. 70:109–115. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li C, Hong L, Liu C, Min J, Hu M and Guo
W: Astragalus polysaccharides increase the sensitivity of SKOV3
cells to cisplatin. Arch Gynecol Obstet. 297:381–386. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen SH, Murphy DA, Lassoued W, Thurston
G, Feldman MD and Lee WM: Activated STAT3 is a mediator and
biomarker of VEGF endothelial activation. Cancer Biol Ther.
7:1994–2003. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai L, Zhang G, Tong X, You Q, An Y, Wang
Y, Guo L, Wang T, Zhu D and Zheng J: Growth inhibition of human
ovarian cancer cells by blocking STAT3 activation with small
interfering RNA. Eur J Obstet Gynecol Reprod Biol. 148:73–80. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kumar J, Fang H, McCulloch DR, Crowley T
and Ward AC: Leptin receptor signaling via Janus kinase 2/Signal
transducer and activator of transcription 3 impacts on ovarian
cancer cell phenotypes. Oncotarget. 8:93530–93540. 2017.PubMed/NCBI
|
|
7
|
Jia Z, Jia Y, Guo FJ, Chen J, Zhang XW and
Cui MH: Phosphorylation of STAT3 at Tyr705 regulates MMP-9
production in epithelial ovarian cancer. PLoS One. 12:e1836222017.
View Article : Google Scholar
|
|
8
|
Hirano T, Ishihara K and Hibi M: Roles of
STAT3 in mediating the cell growth, differentiation and survival
signals relayed through the IL-6 family of cytokine receptors.
Oncogene. 19:2548–2556. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Landen CN, Lin YG, Armaiz Pena GN, Das PD,
Arevalo JM, Kamat AA, Han LY, Jennings NB, Spannuth WA, Thaker PH,
et al: Neuroendocrine modulation of signal transducer and activator
of transcription-3 in ovarian cancer. Cancer Res. 67:10389–10396.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siveen KS, Sikka S, Surana R, Dai X, Zhang
J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3
signaling pathway in cancer: Role of synthetic and natural
inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
|
|
11
|
Harada D, Takigawa N and Kiura K: The role
of STAT3 in non-small cell lung cancer. Cancers (Basel). 6:708–722.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu L, Yang W, Zhang SN and Lu JB:
Alpinetin inhibits lung cancer progression and elevates
sensitization drug-resistant lung cancer cells to cis-diammined
dichloridoplatium. Drug Des Devel Ther. 9:6119–6127.
2015.PubMed/NCBI
|
|
13
|
Wang Z, Lu W, Li Y and Tang B: Alpinetin
promotes Bax translocation, induces apoptosis through the
mitochondrial pathway and arrests human gastric cancer cells at the
G2/M phase. Mol Med Rep. 7:915–920. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang B, Du J, Wang J, Tan G, Gao Z, Wang Z
and Wang L: Alpinetin suppresses proliferation of human hepatoma
cells by the activation of MKK7 and elevates sensitization to
cis-diammined dichloridoplatium. Oncol Rep. 27:1090–1096. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, Yan Z, Liu X, Che S, Wang C and
Yao W: Alpinetin targets glioma stem cells by suppressing Notch
pathway. Tumor Biol. 37:9243–9248. 2016. View Article : Google Scholar
|
|
16
|
Du J, Tang B, Wang J, Sui H, Jin X, Wang L
and Wang Z: Antiproliferative effect of alpinetin in BxPC-3
pancreatic cancer cells. Int J Mol Med. 29:607–612. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ajmala Shireen P, Abdul Mujeeb VM and
Muraleedharan K: Theoretical insights on flavanones as antioxidants
and UV filters: A TDDFT and NLMO study. J Photochem Photobiol B.
170:286–294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huo M, Chen N, Chi G, Yuan X, Guan S, Li
H, Zhong W, Guo W, Soromou LW, Gao R, et al: Traditional medicine
alpinetin inhibits the inflammatory response in Raw 264.7 cells and
mouse models. Int Immunopharmacol. 12:241–248. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malami I, Abdul AB, Abdullah R, Kassim NK,
Rosli R, Yeap SK, Waziri P, Etti IC and Bello MB: Correction: Crude
extracts, flavokawain B and alpinetin compounds from the rhizome of
Alpinia mutica induce cell death via UCK2 enzyme inhibition and in
turn reduce 18S rRNA biosynthesis in HT-29 cells. PLoS One.
12:e1702332017. View Article : Google Scholar
|
|
20
|
Sun X, Lin L, Chen Y, Liu T, Liu R, Wang
Z, Mou K, Xu J, Li B and Song H: Nitidine chloride inhibits ovarian
cancer cell migration and invasion by suppressing MMP-2/9
production via the ERK signaling pathway. Mol Med Rep.
13:3161–3168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park MK, Jo SH, Lee HJ, Kang JH, Kim YR,
Kim HJ, Lee EJ, Koh JY, Ahn KO, Jung KC, et al: Novel suppressive
effects of cardamonin on the activity and expression of
transglutaminase-2 lead to blocking the migration and invasion of
cancer cells. Life Sci. 92:154–160. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang JM, Min J, Li BS, Hong SS, Liu C, Hu
M, Li Y, Yang J and Hong L: Therapeutic effects of punicalagin
against ovarian carcinoma cells in association with β-catenin
signaling inhibition. Int J Gynecol Cancer. 26:1557–1563. 2016.
View Article : Google Scholar : PubMed/NCBI
|
